Phase I Clinical Trial of CA-4948 (Emavusertib) in Combination with FOLFOX Plus Bevacizumab as Frontline Treatment in Patients with Metastatic Colorectal Cancer

Disease Sites:

Colon, Phase I, Rectal

Staging:

Phase I

Age Group:

Adults

Therapies:

Chemotherapy - cytotoxic, Mol. targeted/Immunotherapy/Biologics

Drugs:

Bevacizumab, CA-4948, Fluorouracil (5-FU), Leucovorin, Oxaliplatin

Principal Investigator(s):

Ciombor, Kristen

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

09-01-2025

Trial Type:

Treatment

Protocol ID:

ETCGIP10655

National Clinical Trial ID:

NCT06696768

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available